Ryan Goldstein, President/CEO, and David Lam, Product Manager, attended a Wharton Venture Initiation Program networking event at the Science Center this evening:
Please join Wharton Entrepreneurial Programs and the Science Center in a Networking Event with students from the Wharton Venture Initiation Program on Wednesday, November 19 from 6:00 – 8:00 pm at the University City Science Center. Join us for refreshments and mix with Wharton/Penn’s best and brightest student entrepreneurs along with some of the Philadelphia region’s leading business professionals including numerous alums. This event is a rare opportunity for the area’s VC, angel, legal, and financial services communities to meet and mingle with both rising and seasoned entrepreneurs.
ChronoWake has made some excellent contacts, including leading venture capitalists, angel investors, and legal consultants, in furtherance of our venture objectives.
Thanks to the Wharton Venture Initiation Program and the University City Science Center for this unique opportunity.
Ryan Goldstein, President/CEO, gave a venture pitch earlier today to a panel from the Wharton Venture Initiation Program (Wharton VIP). This round of applications was even more competitive than usual, with 42 applicants (many of whom were Wharton MBA students) for only about 5 available spots. ChronoWake has been officially accepted into this very selective program.
Alumni ventures from this program include Crederity, First Flavor, MicroMRI, BoxMyDorm, Fodius, Humanistic Robotics, TicketLeap, LT Technologies, and more.
Current VIP ventures include Solixia (rang the NASDAQ closing bell), FlyBy, Crave Mobile, YourCampus360, WallStreetOasis.com, and more.
In Phase I, Wharton VIP assists in transitioning from the business overview stage to a fully-developed executive summary or business plan. Through workshops, group advising with an accomplished professional, the use of VIP workspace, and various networking contacts, Wharton VIP helps to hone venture concepts, explore venture viability, and prepare for venture implementation. In Phase II, the ventures are developed further, implementation begins, a post-VIP venture strategy is devised, and seed capital of $2,500 is provided. Acceptance into this exclusive program is a huge step forward for ChronoWake.
Ryan Goldstein, President/CEO, met today with Dr. David Dinges, a leading expert in chronobiology, to assess the feasibility and utility of a venture involving ChronoWake. Generally, the concept behind ChronoWake was determined to be a valid one. If implemented well, the potential market for such a product would be nearly limitless. As such, ChronoWake appears to be a worthwhile endeavor.